MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$7,558,557
Interest income
$215,041
Loss from operations
-$7,773,598
Total operating
expenses
$7,773,598
Selling, general and
administrative (including...
$4,843,615
Research and development
$2,929,983
Back
Back
Income Statement
source: myfinsight.com
Dermata Therapeutics, Inc. (DRMAW)
Dermata Therapeutics, Inc. (DRMAW)